Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07577427

Benign and Malignant Adrenal Gland Surgery: Single Center Experience

PATIENTS AFFECTED BY ADRENAL GLAND DISEASE WITH SURGICAL INDICATION OF ROBOTIC OR LAPAROSCOPIC ADRENALECTOMY

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Adrenal Gland Disease Adrenal Gland Diseases Endocrine System Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ADRENAL GLAND DISEASE

Exclusion criteria

-

Treatment and study plan

Surgery with and without the aid of Indocyanine Green (ICG)

Procedure

NO DIFFERENCES

Other names: ADRENALECTOMY

Primary outcomes

  1. POSTOPERATIVE COMPLICATIONS

    Time frame: FROM ENROLLMENT TO THE END OF TREATMENT AT 5 YEARS

    CLAVIEN-DINDO SCORE

Study contacts

Contact information is provided by the study sponsor or research team.

PAOLO SAPIENZA, PROFESSOR

CONTACT

[email protected]

00390649972157

Sponsors and collaborators

Lead sponsor

University of Roma La Sapienza

Other

Registry information

Acronym: ECOADE

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
May 11, 2026
Registry last updated
May 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.